AL
TME Pharma N.V.
ALTME.PA · PAR
0.12 € +10.71% (+0.01 €)
1M +100.64%
Market Cap 10.7M €
P/E Ratio -
Div. Yield -
ROE 1,273.26%
Piotroski F-Score Weak
1/9Valuation
-
N/A P/E N/A
PEG N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 270.01%
Asset turnover 0.00x
ROE 1,273.26%
Debt
5 /100
High Current ratio 0.57x
Int. coverage -2.67x
Debt/Equity N/A
Stability
80 /100
Stable Beta 0.64x
Profitable years 0
EPS volatility 3.34%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre ALTME.PA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Diede van den Ouden
Employees
12
Headquarters
Berlin